Atrial fibrilation as prognostic factor of myocardial infarction and/or acute heart failure

Kód výsledku v IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F65269705%3A_____%2F11%3A%230001361" target="_blank" >RIV/65269705:_____/11:#0001361 - isvavai.cz</a>

Výsledek na webu

<a href="http://dx.doi.org/10.1556/imas.3.2011.3.4" target="_blank" >http://dx.doi.org/10.1556/imas.3.2011.3.4</a>

DOI - Digital Object Identifier

<a href="http://dx.doi.org/10.1556/imas.3.2011.3.4" target="_blank" >10.1556/imas.3.2011.3.4</a>

Jazyk výsledku

angličtina

Název v původním jazyce

Atrial fibrilation as prognostic factor of myocardial infarction and/or acute heart failure

Popis výsledku v původním jazyce

Atrial fibrillation (AF) is a supraventricular tachyarrhythmia characterized by uncoordinated atrial activation with consequence deterioration of atrial mechanical function. It has an incidence of approximately 6 million people in European Union as a result of the aging population and affects about 1 percent of patients younger than 60 years and about 8 percent of patients older than 80 years [2, 10]. AF is also the most common supraventricular arrhythmia in patients with acute myocardial infarction (MI) and/or acute heart failure (AHF), complicating its course with an incidence between 6?21% in hospitalized patients with MI although recent advances in pharmacological treatment of myocardial infarction has probably changed the impact of this arrhythmiaand vice versa. These two diseases (AF + MI) are a growing health concern all over the world and when one considers the occurrence of these two diseases simultaneously, the relevance of AF in the course of MI and vice versa cannot be ove

Název v anglickém jazyce

Atrial fibrilation as prognostic factor of myocardial infarction and/or acute heart failure

Popis výsledku anglicky

Atrial fibrillation (AF) is a supraventricular tachyarrhythmia characterized by uncoordinated atrial activation with consequence deterioration of atrial mechanical function. It has an incidence of approximately 6 million people in European Union as a result of the aging population and affects about 1 percent of patients younger than 60 years and about 8 percent of patients older than 80 years [2, 10]. AF is also the most common supraventricular arrhythmia in patients with acute myocardial infarction (MI) and/or acute heart failure (AHF), complicating its course with an incidence between 6?21% in hospitalized patients with MI although recent advances in pharmacological treatment of myocardial infarction has probably changed the impact of this arrhythmiaand vice versa. These two diseases (AF + MI) are a growing health concern all over the world and when one considers the occurrence of these two diseases simultaneously, the relevance of AF in the course of MI and vice versa cannot be ove

Druh

J_x - Nezařazeno - Článek v odborném periodiku (Jimp, Jsc a Jost)

CEP obor

FA - Kardiovaskulární nemoci včetně kardiochirurgie

OECD FORD obor

—

Projekt

—

Návaznosti

V - Vyzkumna aktivita podporovana z jinych verejnych zdroju

Rok uplatnění

2011

Kód důvěrnosti údajů

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Název periodika

Interventional Medicine and Applied Science

ISSN

2061-1617

e-ISSN

—

Svazek periodika

3

Číslo periodika v rámci svazku

3

Stát vydavatele periodika

HU - Maďarsko

Počet stran výsledku

4

Strana od-do

104-107

Kód UT WoS článku

—

EID výsledku v databázi Scopus

—